Abstract Aims Advanced glycation endproducts (AGEs) are sugar-modified adducts which
arise during non-enzymatic glycoxidative stress. These compounds may become …

Advanced glycation end products (AGEs) are protein-bound compounds derived from
glycaemic and oxidative stress that contain fluorescent properties, which can be non …

OBJECTIVE The development of periarticular thickening of skin on the hands and limited
joint mobility (cheiroarthropathy) is associated with diabetes and can lead to significant …

OBJECTIVE The Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications (DCCT/EDIC) study continues to address knowledge gaps …

The results of the Diabetes Control and Complications Trial (DCCT) have given rise to much
encouragement in the battle to stave off the complications of type 1 diabetes, showing …

Glycation is important in the development of complications of diabetes mellitus and may
have a central role in the well-described glycaemic memory effect in develo** these …

OBJECTIVE To determine whether type 1 diabetes and its complications are associated with
bone geometry and microarchitecture. RESEARCH DESIGN AND METHODS This cross …

Abstract Context Type 1 diabetes (T1D) is characterized by high fracture risk, yet little is
known regarding diabetes-related mechanisms or risk factors. Objective Determine whether …

Advanced glycation end-products (AGEs) are heterogeneous compounds of irreversible
adducts principally derived from nonenzymatic glycation and glycoxidation of proteins. An …

OBJECTIVE To determine whether skin intrinsic fluorescence (SIF) is associated with long-
term complications of type 1 diabetes (T1D) and, if so, whether it is independent of chronic …